Johnson & Johnson Submits First Global Application for Nipocalimab, Pioneering Treatment for Generalized Myasthenia Gravis

Johnson & Johnson  announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for nipocali...

August 30, 2024 | Friday | News
Merck KGaA Initiates Global Phase III MyClad Trial for Potential First Oral Treatment of Generalized Myasthenia Gravis

MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (...

August 29, 2024 | Thursday | News
Novartis’ Leqvio® (inclisiran) Outperforms Placebo and Ezetimibe in Phase III V-MONO Study for LDL-C Reduction

Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C r...

August 29, 2024 | Thursday | News
Eli Lilly Launches Affordable Zepbound® Single-Dose Vials for Self-Pay Patients, Offering Over 50% Savings on Obesity Treatment

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incr...

August 28, 2024 | Wednesday | News
Pfizer Launches "PfizerForAll" to Streamline Healthcare Access for Millions of Americans

PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, C...

August 28, 2024 | Wednesday | News
Label Expansion Makes Omnipod 5 Commercially Available to 6 Million People Living with Insulin-Requiring Type 2 Diabetes

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that its groundbreaki...

August 27, 2024 | Tuesday | News
LIXTE Biotechnology and Netherlands Cancer Institute Dose First Patient in Roche-Supported Trial for Metastatic Colorectal Cancer

LIXTE Biotechnology Holdings, Inc. announced the dosing of the first patient in a new clinical trial in collaboration with the Netherlands Cancer In...

August 27, 2024 | Tuesday | News
BeiGene's Investigational BTK Degrader BGB-16673 Receives FDA Fast Track Designation for Relapsed CLL/SLL

BeiGene, a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BGB-16673, an ...

August 27, 2024 | Tuesday | News
India's BioE3 Policy: A Strategic Leap Towards Global Biomanufacturing Leadership

Indian Union Cabinet, chaired by Prime Minister Shri Narendra Modi, recently approved the BioE3 (Biotechnology for Economy, Environment, and Empl...

August 26, 2024 | Monday | News
Pfizer and BioNTech Launch KP.2-Adapted COVID-19 Vaccine for 2024-2025 Season

The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of...

August 23, 2024 | Friday | News
FDA Accepts Application for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Acceptance based on Phase 3 CheckMate -9DW trial results demonstrating improved survival with Opdivo (nivolumab) plus Yervoy(ipilimumab) compared to in...

August 22, 2024 | Thursday | News
Sustainability Emerges as a Key Differentiator Amidst Momentum Challenges in Biopharma, Reports Global Survey by Cytiva

Sustainability: A Key Differentiator as Biopharma Faces  Momentum Challenges, Global Survey by Cytiva Reports  Companies with a proven commitm...

August 22, 2024 | Thursday | News
Monkeypox Resurgence: What the Data Reveals About Its Spread and Global Impact

  Mpox is an infectious disease spread through close contact with contagious individuals or infected animals. Most people recover fully, but in some ...

August 21, 2024 | Wednesday | Reports
Roche Strengthens Global Response to Mpox Outbreak with Advanced PCR Testing Solutions

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) te...

August 21, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close